An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
- Conditions
- Childhood CancerCardiomyopathy, Primary
- Registration Number
- NCT05617391
- Lead Sponsor
- St. Jude Children's Research Hospital
- Brief Summary
The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer.
Primary Objective
To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk.
Secondary Objective
To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.
- Detailed Description
The proposed study is looking to compare the 30 second ECG read from a smartwatch to the clinical ECG during a SJLIFE scheduled ECG appointment.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1300
- SJLIFE participant and 22 years of age or older at time of enrollment
- Participant or legal guardian is able and willing to give informed consent
- At least 5 years after childhood cancer diagnosis
- Been diagnosed with cardiomyopathy on previous SJLIFE ECG
- Currently on heart medication
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Apple Smartwatch ECG 30-second recording Baseline To be obtained during the SLIFE Human Performance Lab appointment, collected immediately after recording of the standard 12-lead ECG. A study team member will place an Apple Smartwatch Series 7 on the participant's wrist. The participant will be instructed to start the ECG, which will be a 30-second recording process. Once captured, the data will be automatically transferred to the IOS application on the study iPhone. This will be assessed with the standard 12-lead ECG recording to determine concordance of the two ECGs.
Standard 12-lead ECG Baseline To be obtained during SLIFE Human Performance Lab appointment. Participant will receive a resting (supine) 12-lead ECG using a GE Mac 2000 Resting ECG System (General Electric Healthcare, Milwaukee, WI, USA). This will be assessed with the Apple Smartwatch ECG recording to determine concordance of the two ECGs.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
St. Jude Children's Research Hospital
🇺🇸Memphis, Tennessee, United States